Top Reasons Home Health and Hospice Agencies Fail Due Diligence

Selling a home health or hospice agency can be one of the most rewarding events of an owner’s career. But for many agencies, the sale process stalls—or completely collapses—during due diligence.

At Fleetridge Pacific, we specialize in mergers and acquisitions for home health and hospice agencies. We’ve seen strong businesses command premium valuations. We’ve also seen promising deals fall apart after buyers dig into the details.

If you’re considering selling your agency in the next 1–3 years, understanding the most common due diligence pitfalls can help you protect value and close successfully.

Below are the top reasons home health and hospice agencies fail due diligence.

1. The Business Relies Too Heavily on the Owner

One of the biggest red flags for buyers is an agency that cannot operate without the owner.

If the owner:

Manages key referral relationships personally
Oversees daily clinical operations
Handles billing and compliance directly
Makes all major decisions without a leadership team

…buyers immediately see transition risk.

Why this kills deals:
Buyers are purchasing future cash flow. If revenue depends heavily on the seller’s personal involvement, there’s uncertainty about what happens after closing. This increases perceived risk, reduces valuation, or causes buyers to walk away entirely.

How to fix it:

Build a strong clinical and operational leadership team
Delegate referral relationship management
Create documented systems and processes
Gradually step back from daily operations

An agency that runs smoothly without the owner commands significantly higher valuations.

2. Client or Referral Source Concentration

Another common due diligence failure is excessive concentration.

Examples:

One referral source generates over 20% of admissions
A single managed care contract represents a large percentage of revenue
A small number of patients make up a disproportionate share of census or revenue

Why this kills deals:
If one hospital, physician group, or payer changes course, revenue can drop overnight. Buyers view concentration as unstable and risky.

In home health and hospice, referral diversification is critical. Strong agencies typically demonstrate:

Multiple consistent referral partners
A diversified payer mix
Stable, recurring admission trends

How to fix it:

Develop broader hospital and physician relationships
Track and monitor referral source percentages
Reduce dependency on any single payer or contract

Diversification directly supports stronger valuation multiples.

3. Declining Revenue, Sales, or Patient Census

Flat or declining performance during the 12–24 months leading up to a sale is one of the fastest ways to lose buyer confidence.

Buyers carefully analyze:

Revenue trends
Admission growth
Average daily census
EBITDA performance
Sales pipeline and referral activity

Even if an agency has historically performed well, recent downward trends raise questions:

Has the market changed?
Has a competitor taken a share?
Are compliance issues affecting growth?
Is management disengaged ahead of a sale?

Why this kills deals:
Buyers value predictable and growing cash flow. Declines create uncertainty and reduce purchase price—sometimes dramatically. Lenders see declining admissions and sales as a significant risk as it could directly impact the buyers ability to cover the debt payments.

How to fix it:

Maintain strong sales efforts up to and through the sale process
Track KPIs monthly
Address operational issues before going to market
Avoid “coasting” once you decide to sell

The strongest exit outcomes happen when agencies go to market during growth—not decline.

4. High Staff Turnover

Workforce stability is everything in home health and hospice.

During due diligence, buyers evaluate:

RN, LVN, therapist, and aide turnover rates
Tenure of clinical leadership
Recruitment pipelines
Compensation competitiveness
Use of contract labor

High turnover raises serious concerns:

Continuity of patient care
Referral partner confidence
Clinical compliance risk
Margin sustainability

Why this kills deals:
Recruiting and onboarding clinicians is expensive. If buyers believe they’ll inherit a staffing crisis, they’ll discount the purchase price—or abandon the deal entirely.

How to fix it:

Track and improve retention metrics
Strengthen culture and leadership
Ensure competitive compensation structures
Develop strong clinical supervision systems

Agencies with stable teams and long-tenured clinical leaders are significantly more attractive to buyers.

5. Statutory and Clinical Compliance Issues (Medicare Conditions of Participation)

In certified home health and hospice agencies, compliance is not optional—it is foundational to value.

Medicare’s Conditions of Participation (CoPs) establish strict standards governing how agencies operate, deliver care, document services, and bill for reimbursement. During due diligence, buyers and their clinical consultants closely examine whether an agency is truly operating in accordance with these regulations.

Common red flags include:

Incomplete or inconsistent documentation
Failure to properly complete and submit the Plan of Care (Form 485)
Missed or improperly timed skilled nursing visits
Orders not signed or dated appropriately
Care not delivered in accordance with physician orders
Survey deficiencies or unresolved plans of correction
Billing inconsistencies tied to documentation gaps

For example, if a physician orders skilled nursing visits at a defined frequency, and the agency fails to meet that frequency—or cannot clearly document why deviations occurred—this can create significant compliance exposure. Similarly, improperly executed Form 485s or gaps in plan-of-care documentation can raise billing and repayment concerns.

Why this kills deals:
Buyers are not just purchasing revenue—they are assuming regulatory risk. If documentation does not clearly support billed services, it creates the potential for audits, recoupments, penalties, or worse. Even minor but repeated deficiencies can trigger price reductions, indemnification holdbacks, or deal termination.

How to fix it:

Conduct regular internal clinical audits
Ensure timely and accurate completion of Plans of Care (485s)
Strengthen oversight of visit frequency compliance
Maintain strong QA and performance improvement (QAPI) programs
Address survey deficiencies immediately and thoroughly

Agencies with clean surveys, strong documentation practices, and well-managed compliance systems command significantly more buyer confidence—and stronger valuations.

6. Overstated or Poorly Supported Financials

In home health and hospice transactions, financial credibility is everything. One of the most common—and most damaging—due diligence issues is overstated or poorly supported revenue.

Accrual accounting in Medicare home health can be complex. There is more than one acceptable method of recognizing revenue, and reimbursement is often estimated before final payment is fully reconciled. Most agencies rely on contractual allowances to account for the difference between anticipated reimbursement and actual collections.

When these contractual allowances are not reviewed and adjusted regularly, revenue can become overstated.

Other common financial red flags include:

Unreconciled accounts receivable
Aging AR with large balances over 90–120 days
Significant write-offs after year-end
Inconsistent revenue recognition policies
EBITDA adjustments that are unsupported or overly aggressive

Why this kills deals:
Buyers validate earnings during due diligence. If reported revenue does not convert to cash—or if historical financials require downward adjustments—trust erodes quickly. Even if the issue is unintentional, buyers begin to question management credibility, forecasting accuracy, and overall financial controls.

In many cases, overstated financials lead to:

Reduced purchase price
Re-trading of deal terms
Earnout structures to offset uncertainty
Increased escrow or indemnification holdbacks
Or complete deal termination

How to fix it:

Reconcile contractual allowances monthly or at least quarterly
Perform regular AR and revenue recognition reviews
Make sure financial statements tie out to tax returns
Clean up aging receivables before going to market
Work with a healthcare-experienced CPA
Consider a sell-side Quality of Earnings (QofE) review prior to going to market

Clean, supportable, and transparent financials build buyer confidence—and confidence supports stronger valuation multiples.

The Bigger Picture: Risk = Lower Valuation

In mergers and acquisitions, valuation is a function of two primary factors:

Cash flow
Risk

When buyers identify operational weaknesses during due diligence, perceived risk increases—and multiples decrease.

The good news? Most due diligence failures are preventable with proper planning.

How to Prepare for a Successful Sale

If you’re 1–3 years away from considering a transaction, now is the time to prepare.

At Fleetridge, we help home health and hospice agency owners:

Identify value gaps before going to market
Strengthen operational infrastructure
Reduce concentration risk
Position the business for maximum valuation
Navigate the entire M&A process confidentially

Preparation can be the difference between an average outcome and a premium and seamless exit.

Final Thoughts

Due diligence isn’t designed to derail your deal—it’s designed to validate value.

The agencies that close successfully share common characteristics:

Diversified referrals
Stable and growing census
Strong clinical leadership
Reduced owner dependency
Consistent financial performance

If you’re considering selling your home health or hospice agency, understanding these pitfalls is the first step toward a successful exit.

At Fleetridge Pacific, we specialize exclusively in advising home health and hospice agency owners through every stage of the M&A process—from pre-sale preparation to successful closing—and if you’re considering a sale or simply want to understand what your agency is worth, contact us for a confidential conversation about how we can help you maximize value and navigate the process with confidence.

Email or call us today at (888) 220-2270 for a confidential consultation.